Our Attendees Include:

• Adult and pediatric hepatology experts.
• Clinical, basic, and translational researchers.
• Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
• Primary care physicians.
• Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
• Trainees, and students in the disciplines listed above.
• Patient advocates and patients.

Topics : 

• AASLD The Live Meeting 2021

  AASLD The Live Meeting 2021

  Day 1

  • AASLD-ASGE Endoscopy Course
  • AASLD-ILTS Transplant Course
  • AASLD-Japan Society of Hepatology Joint Symposium
  • General Hepatology Update
  • Hepatology Associates Course
  • Postgraduate Course – Part I
  • Postgraduate Course – Part II
  • PG Course – Part III
  • Value-based Medicine in Hepatology
  • Social Media Session

   

  Day 2

  • Presidential Welcome and President’s Choice Lecture
  • 2021 Academic Debates
  • AASLD Distinguished Awards
  • AASLD-NASPGHAN Pediatric Symposium
  • Alcohol-associated Liver Disease SIG
  • Career Development Workshop
  • Cholestatic and Autoimmune Liver Diseases SIG
  • Clinical Practice SIG
  • Hans Popper Basic Science State-of-the-Art Lecture
  • Hepatitis B SIG
  • Hepatitis C SIG
  • Hepatotoxicity SIG
  • Liver Cancer SIG
  • Liver Cell Biology SIG
  • Nonalcoholic Fatty Liver Disease SIG
  • Liver Fibrosis SIG
  • Liver Transplantation and Surgery SIG
  • Patient Annual Forum and Meet & Greet Networking
  • Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part I
  • Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part II
  • Portal Hypertension Clinical and Experimental SIG
  • Practice Guidelines Workshop
  • Public Health – Health Care Delivery SIG
  • Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture

   

  Day 3

  • AASLD & AASLD Foundation Awards & Honors Ceremony
  • Cirrhosis Improving Quality through Patient Empowerment
  • Diversity Workshop
  • HBV Cures v2
  • HBV Global Symposium
  • Hepatology Associates SIG
  • How Physician-Patient Partnerships Can Improve Liver Disease Care & Research
  • Parallel-1 Advances with Approved HBV Therapies
  • Parallel-2 Health Services and Public Health
  • Parallel-3 Metabolic and Genetic Disease
  • Parallel-4 COVID-19 Clinical
  • Parallel-5 Pediatric Hepatology Metabolic and Genetic Diseases
  • Parallel-6 Experimental and Translational Portal Hypertension and ACLF
  • Parallel-7 Immunosuppression, Outcomes, Complications
  • Parallel-8 HBV Cascade of Care, Natural History and Diagnostics
  • Parallel-9 COVID-19 Translational and Clinical
  • Postgraduate Course Live Q&A Session
  • Presidential Plenary- Liver Transplant
  • Transplant Surgery Workshop Part I
  • Transplant Surgery Workshop Part II
  • Women’s Health Program

  Day 4

  • AASLD_ALEH Joint Symposium
  • AASLD_ASGE Endoscopy Course- Live Q&A Session
  • AASLD_ILTS Transplant Course- Live Q&A Session
  • Clinical Research Workshop – Part I
  • Clinical Research Workshop – Part II
  • COVID-19 and the Liver Symposium
  • Grit, Grace, Gratitude, and Resilienc What You Wish Your Doctors Knew About You
  • Making an Impact Where You Are Patient Voices as a Vehicle for Change
  • Nutrition 101 for Patients with Chronic Liver Disease
  • Panel Discussion Saving More Lives Forward from A Burden of Genius
  • Parallel-10- Diagnostics and Biomarkers of NAFLD
  • Parallel 11- Healthcare Quality and Access in Hepatology
  • Parallel 12- Donor and Allocation Issues, Living and Split Donor Liver Transplantation
  • Parallel 13- Novel HBV Therapies and Approaches
  • Parallel 14- Hepatitis C Oral Session
  • Parallel 15- Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases
  • Parallel 16- Experimental and Translational Advances in Alcohol-Associated Liver Disease
  • Parallel 17- NAFLD and NASH- Predicting Outcomes and Response to Interventions
  • Parallel 18- Mechanisms of Cholestatic Liver Injury
  • Parallel 19- Clinical Advances in Alcohol-Associated Liver Disease
  • Parallel 20- Hepatobiliary Neoplasia- Clinical Oral Session
  • Parallel 21- NAFLD and NASH- Clinical Trials of Novel Therapeutics
  • Parallel 22- Portal Hypertension- Risk Stratification and Treatment for Varices
  • Parallel 23- Cell and Molecular Biology
  • Parallel 24- Hepatobiliary Neoplasia- Experimental
  • Translational Oral SessionPresidential Plenary- Clinical and Translational
  • Viral Hepatitis Elimination Session

   

  Day 5

  • Basic Science Debrief
  • Clinical Hepatology Debrief
  • Emerging Trends Symposium
  • Hepatitis Debrief
  • Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture
  • Leon Schiff State-of-the-Art Lecture
  • NAFLD Debrief
  • NAFLD Debrief 2
  • Parallel 25- Portal Hypertension Clinical
  • Parallel 26- Liver Fibrogenesis and Non-Parenchymal Cell Biology
  • Parallel 27- Diversity, Equity, and Inclusion in Liver Disease Care
  • Parallel 28- Gut Liver Axis and Microbiome
  • Parallel 29- NAFLD and NASH- Management and Outcomes in the Clinic
  • Parallel 30- Genomics and Precision Medicine
  • Parallel 31- Clinical_ Translational Research in Pediatric Hepatology
  • Parallel 32- Clinical Acute on Chronic Liver Failure
  • Parallel 33- Experimental Advances in NAFLD
  • Parallel 34- Basic Science Research in Pediatric Hepatology
  • Parallel 35- Viral Hepatitis Oral Session (Non-HBV, Non-HCV)
  • Patient Debrief
  • Practice Guidelines Debrief for Patients
  • Presidential Plenary- Basic and Translational
  • The Liver Meeting Closing Remarks